A simple strategy could make first-line antibiotics more effective against resistant bacteria
Researchers have identified a single, simple metric to inform medication regimen design that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke University, revealed that a regimen based on a pathogen’s recovery time could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line antibiotics to clear many resistant infections.
Meredith has already begun lab work to create such a database, and early tests are confirming her model’s predictions.
The study appears in PLOS Computational Biology on April 23, 2015.
“Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently,” said Meredith. “We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible.”
The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the infection might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.
“You can think of this as a race between the cells and the antibiotics,” said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith’s advisor. “Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate.”
When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics such that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.
Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith’s computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.
Read more: Finding New Life for First-Line Antibiotics
The Latest on: Antibiotics
[google_news title=”” keyword=”Antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotics
- 27% of ED visits tied to inappropriate antibiotics, study suggestson May 17, 2024 at 10:40 am
Researchers found 27.6% of visits resulted in inappropriate antibiotic prescribing. Of these, 54% had diagnoses where antibiotics may have been wrongly prescribed, while 46% involved conditions ...
- Govt lens on misuse of antibiotics, DCGI seeks report within 2 weekson May 17, 2024 at 10:16 am
This comes in the backdrop of excessive and irrational use of antibiotics in India which fail to work in patients when they are routinely exposed to these drugs.
- What to know about MeCure, the company set to produce Nigeria’s first antibioticson May 17, 2024 at 8:23 am
Mecure Industries Plc, a pharmaceutical company in Nigeria, has revealed that it has secured approval from NAFDAC to launch the ...
- Australia’s Recce, Etana team up to develop synthetic antibiotics in Indonesiaon May 16, 2024 at 5:00 pm
Signed in February, the agreement aims to develop the new class of antibiotics to address the growing issue of drug-resistant superbugs, which can cause previously treatable infectious diseases to ...
- Suppressive Antibiotics for Joint Infections: Benefit Debate Unveiledon May 16, 2024 at 9:00 am
BENEFITS of suppressive antibiotic therapy (SAT) may be limited, according to new research. SAT is a routine strategy for managing periprosthetic joint infections (PJI), but determining the optimal ...
- Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitalson May 16, 2024 at 12:32 am
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The ...
- Woman becoming resistant to antibiotics after UTIson May 15, 2024 at 2:54 pm
A woman who needs antibiotics almost every other month says her growing resistance to them has caused "stress and suffering". Sian Jones, from Vale of Glamorgan, has spoken about her experience to ...
- Fungal foray-ing and the search for new antibioticson May 15, 2024 at 10:38 am
Could the answer to one of our most pressing health needs be hiding in Aotearoa’s bush? On Our Changing World this week, Liz Garton heads out on a foray to discover some of our fungal gems, and she ...
- New bacteria breakthrough may make existing antibiotics more effectiveon May 15, 2024 at 1:50 am
Microbiologists at Queen’s University have made a breakthrough in bacteria research which could lead to increased effectiveness of currently available antibiotics, helping in the global fight against ...
- Overuse of antibiotics in newborns with suspected sepsison May 7, 2024 at 5:46 am
Newborns in Sweden are given antibiotics for suspected sepsis to an unjustified extent. This is according to a study by the University of Gothenburg ...
via Bing News